Romania's Antitrust Watchdog Fines Boehringer Ingelheim RCV RON128M For Abuse Of Dominant Position

yesterday, 12:33 By Ecaterina Craciun

Romania's Competition Council has fined Boehringer Ingelheim RCV GmbH & Co KG (Austria) a total RON128.47 million (EUR25.81 million) for abusing its dominant position in Romania’s market for medicines treating chronic obstructive pulmonary disease (COPD).

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

 
Keywords:
Competition Council
, Boehringer Ingelheim RCV